Objective
There are four basic objectives to the proposal:
1. Development of new constructs which express antiviral genes directed against HIV.
2. Demonstration of expression of these genes in eukaryotic cells. Stable and, where appropriate, inducible expression.
3. Assessment of the ability of these antiviral genes to inhibit replication of HIV which has been introduced into these cells.
4. Efficient delivery of such antiviral constructs, firstly to established the cell lines, secondly to primary human T-cells derived from peripheral blood, and thirdly to haemopoietic stem cells. These will be derived from CD34 cells from umbilical cord and bone marrow cell populations or from peripheral blood.
A necessary accompaniment to these studies is that the delivery of such antiviral constructs should be performed in as safe a manner as possible. Thus, ensuring safety will be paramount during these experiments and in the gene therapeutics being developed.
These objectives are similar to those currently being attempted by groups elsewhere, notably in the USA. Our grouping however has an unusual combination of expertise in the diverse areas of gene delivery and in HIV molecular biology. All the collaborators are experts within their fields. Whilst it is possible that commercially exploitable gene therapeutics will derive from this collaboration it is not certain there is an equivalent group in industry.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences medical biotechnology genetic engineering gene therapy
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences medical biotechnology cells technologies stem cells
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
CB2 2QQ Cambridge
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.